We are live on
!
Find out more
BCV
Banque Cantonale Vaudoise Portfolio holdings
AUM
$722M
1-Year Est. Return
30.45%
This Fund
S&P 500
This Quarter
Est. Return
+16.26%
1 Year Est. Return
+30.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$1.94B
(-73%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-60.67%
Top 10 Holdings %
Top 10 Hldgs %
58.22%
Holding
956
New
82
Increased
260
Reduced
372
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$21.9M |
| 2 |
AstraZeneca
AZN
|
+$11.4M |
| 3 |
AMRZ
Amrize Ltd
AMRZ
|
+$10.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.1M |
| 5 |
Walmart Inc
WMT
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$85.9M |
| 2 |
Amazon
AMZN
|
+$49.2M |
| 3 |
Applied Materials
AMAT
|
+$15.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$14.3M |
| 5 |
Advanced Micro Devices
AMD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.44% |
| 2 | Healthcare | 20.15% |
| 3 | Communication Services | 15.97% |
| 4 | Industrials | 10.45% |
| 5 | Materials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
S&P Global
SPGI
$131B
| $5.55K | ﹤0.01% |
13,626
-2,262
| -14% | -$955K |
|
252
Medtronic
MDT
$120B
| $5.52K | ﹤0.01% |
70,513
+2,897
| +4% | +$234K |
|
253
F5
FFIV
$22.1B
| $5.34K | ﹤0.01% |
12,833
-1,534
| -11% | -$545K |
|
254
Progressive
PGR
$127B
| $5.27K | ﹤0.01% |
24,109
-7,800
| -24% | -$1.57M |
|
255
Thermo Fisher Scientific
TMO
$227B
| $5.12K | ﹤0.01% |
10,203
-915
| -8% | -$439K |
|
256
Nu Holdings
NU
$74.2B
| $5.01K | ﹤0.01% |
375,230
+5,621
| +2% | +$75.8K |
|
257
Vertex Pharmaceuticals
VRTX
$138B
| $4.98K | ﹤0.01% |
10,020
+1,093
| +12% | +$484K |
|
258
Lowe's Companies
LOW
$115B
| $4.98K | ﹤0.01% |
22,570
-10,105
| -31% | -$2.29M |
|
259
McKesson
MCK
$106B
| $4.92K | ﹤0.01% |
6,511
-94
| -1% | -$74.5K |
|
260
Zoetis
ZTS
$31.3B
| $4.79K | ﹤0.01% |
66,623
+14,688
| +28% | +$1.38M |
|
261
SPDR Gold Trust
GLD
$149B
| $4.77K | ﹤0.01% |
12,943
-267
| -2% | -$111K |
|
262
Okta
OKTA
$29.8B
| $4.71K | ﹤0.01% |
34,480
+1,724
| +5% | +$162K |
|
263
Johnson Controls International
JCI
$87.8B
| $4.59K | ﹤0.01% |
31,416
-3,577
| -10% | -$505K |
|
264
Teradyne
TER
$55.8B
| $4.56K | ﹤0.01% |
9,421
+4,320
| +85% | +$1.63M |
|
265
Realty Income
O
$58B
| $4.44K | ﹤0.01% |
71,653
+49,636
| +225% | +$3.09M |
|
266
Rubrik
RBRK
$19.4B
| $4.39K | ﹤0.01% |
54,751
+8,015
| +17% | +$504K |
|
267
O'Reilly Automotive
ORLY
$71.1B
| $4.36K | ﹤0.01% |
47,336
+4,643
| +11% | +$424K |
|
268
Hewlett Packard
HPE
$69B
| $4.36K | ﹤0.01% |
96,594
+14,396
| +18% | +$520K |
|
269
Yum! Brands
YUM
$41.1B
| $4.34K | ﹤0.01% |
27,161
+11,927
| +78% | +$1.85M |
|
270
First Trust RBA American Industrial Renaissance ETF
AIRR
$9.49B
| $4.25K | ﹤0.01% |
31,860
+485
| +2% | +$61.2K |
|
271
iShares Gold Trust
IAU
$65.8B
| $4.11K | ﹤0.01% |
54,486
+200
| +0.4% | +$17K |
|
272
Idexx Laboratories
IDXX
$42.2B
| $4.09K | ﹤0.01% |
7,761
-1,452
| -16% | -$814K |
|
|
NBIS
273
Nebius Group N.V.
NBIS
$61.5B
| $4.08K | ﹤0.01% |
14,760
+14,336
| +3,381% | +$2.84M |
|
274
Keurig Dr Pepper
KDP
$44.3B
| $4.04K | ﹤0.01% |
123,515
+8,957
| +8% | +$261K |
|
275
Keysight
KEYS
$55.7B
| $4.03K | ﹤0.01% |
11,501
+8,693
| +310% | +$2.96M |
|
Similar funds
AO
HS
GFM
SFG
ACM
SCM
SP
SFS
Banque Cantonale Vaudoise's Q2 2026 Portfolio in Review
As of Q2 2026, Banque Cantonale Vaudoise held 956 positions worth $722M, down 73% from $2.66B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Banque Cantonale Vaudoise withdrew a net $438M in Q2 2026, closing 140 positions and reducing 372 holdings. Its most notable exit was Apple, an estimated $85.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Banque Cantonale Vaudoise opened a new position in AstraZeneca worth $11.3M.
- Banque Cantonale Vaudoise's largest Q2 2026 buy was AstraZeneca: 60,462 shares worth $11.3M.
- Banque Cantonale Vaudoise added most to Microsoft in Q2 2026, an estimated $21.9M increase.
- Banque Cantonale Vaudoise's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $14.3M.
- Banque Cantonale Vaudoise fully exited Apple in Q2 2026, selling an estimated $85.9M.
- Banque Cantonale Vaudoise's ten largest holdings make up 58% of its $722M portfolio in Q2 2026.
- Banque Cantonale Vaudoise opened 82 new positions and closed 140 in Q2 2026.
- Banque Cantonale Vaudoise's portfolio value fell 73% quarter-over-quarter to $722M.
Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.